European Digital Pathology Market to Reach $3,244.6M by 2035, Driven by AI Platforms

European digital pathology market was valued at $463.3 million in 2025 and is projected to reach $3,244.6 million by 2035, growing at a CAGR of 21.6% during the forecast period (2026–2035). The use of artificial intelligence and machine learning is increasingly shaping the European digital pathology market, particularly within automated diagnostic workflows. AI-based image analysis and pattern recognition are being applied to support early disease identification, optimize case prioritization, and improve consistency in high-throughput laboratory environments. As healthcare systems experience growing pressure from aging populations and workforce limitations, interest in automated diagnostic solutions continues to increase, reflecting a broader shift toward efficiency-driven and data-supported pathology practices.

Browse the full report description of “European Digital Pathology Market Size, Share & Trends Analysis Report by Product (Scanner Device, Software and Storage System), by Application (Teleconsultation, Disease Diagnosis and Drug Discovery and Other) and by End-User (Biotechnology & Pharmaceutical Companies, Hospitals and Others), Forecast Period, (2026-2035)” of https://www.omrglobal.com/industry-reports/european-digital-pathology-market

Major market participants are increasingly introducing AI-powered digital pathology platforms as part of their product development strategies. These platforms combine whole-slide imaging with advanced algorithms to support image interpretation, workflow automation, and quantitative analysis. By integrating AI capabilities, companies aim to improve diagnostic reproducibility, reduce manual workload for pathologists, and support scalable deployment across clinical and research settings. For instance, in December 2024, NOUL launched its AI-powered miLab BCM in the European market, marking a significant step in advancing automated and precision blood diagnostics. The system improves testing efficiency and accuracy, helping address healthcare pressures linked to aging populations.

Italy became the first European market to adopt miLab BCM, following earlier uptake of miLab™ MAL, driven by rising demand for routine blood testing. Furthermore, in November 2023, Dedalus Group and Ibex Medical Analytics launched a fully integrated, end-to-end AI-powered digital pathology solution for cancer diagnosis in Europe. Now commercially available across major European markets, the solution combines Dedalus’ anatomic pathology information systems with Ibex’s AI-driven cancer diagnostics. The platform enables full digitization of pathology laboratories, supporting AI-assisted case prioritization, advanced image analysis, and consistent diagnostic outcomes.

Innovation and Expansion Shape Europe’s Digital Pathology Market

The major companies operating in the European digital pathology market include 3DHISTECH Ltd., Agfa HealthCare NV, Dedalus Group, Philips N.V., and Leica Biosystems Nussloch GmbH among others. Market players are expanding infrastructure and deploying AI-powered digital pathology solutions to enhance diagnostic accuracy and efficiency. These initiatives focus on streamlining workflows, supporting cross-site collaboration, and improving patient care across Europe.

• In October 2025, SYNLAB inaugurated its largest medical centre in Italy, SYNLAB Manifattura Firenze, marking a key milestone in the Group’s international growth strategy. The 4,000-square-metre facility in Florence offers advanced diagnostics, imaging, specialist consultations, and a dedicated women’s health area, serving over 200,000 patients annually. The centre combines advanced technology, patient-focused care, and sustainable infrastructure. 

• In September 2025, PathAI partnered with a group of Austrian pathology laboratories to deploy its AISight Dx digital pathology system across five sites in Vienna, St. Pölten, and Villach. The platform, CE-IVDR marked for Europe, the UK, and Switzerland, integrates whole-slide imaging, case management, workflow orchestration, and AI to support digital transformation. The deployment aims to streamline workflows, enable cross-site collaboration, and maintain consistent diagnostic quality across participating laboratories, including ADK Diagnostik, PIZ – patho im zentrum, Patho Pipp, and several Vienna- and Hall-based practices.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product
  • By Application
  • By End-User
• Competitive Landscape - 3DHISTECH Ltd., Agfa HealthCare NV, Dedalus Group, Philips N.V., and Leica Biosystems Nussloch GmbH among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Digital Pathology Market Report Segment

By Product Type

• Scanner Device
• Software
• Storage System

By Application

• Teleconsultation
• Disease Diagnosis
• Drug Discovery
• Other

By End-User

• Biotechnology & Pharmaceutical Companies
• Hospitals
• Others

European Digital Pathology Market Report Segment by Region

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-digital-pathology-market